Imint delivered a solid Q3 report showing growth, black numbers, and positive cash flow. The company, however, states that its revenues during the coming quarters will be negatively affected by volume caps in some of its agreements. Although believing that the case remains unchanged, we have revised our forecasts, resulting in an updated fair value.
Read more and download the research update: http://bit.ly/2zlnYOT
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking. https://www.redeye.se/about/
